Inspire IVF Launches ASEAN's First Telemedicine IVF, Integrating AI to Transform Infertility Treatment Elevating Borderless Fertility Care, Connecting Patients Worldwide to Treatment in Thailand

The platform was developed under the guiding principle of "Simplicity in Every Step." It aims to streamline the treatment process, improve accessibility to medical teams, and provide a more personalized and continuous patient experience. This is particularly beneficial for patients residing in other provinces within Thailand and international patients who wish to plan their treatment in advance of their arrival in Thailand.

Inspire IVF stands as an internationally accredited fertility treatment center. It is the first specialized fertility clinic in the Asia Pacific region to receive both AACI (American Accreditation Commission International) and ISO 9001 certifications from the United States, signifying global benchmarks for quality and safety in medical services.

Furthermore, Inspire IVF is the first IVF center in Southeast Asia to achieve TEMOS certification from Germany. This standard evaluates the quality of medical services for international patients (International Patient Care), demonstrating the readiness of its treatment system, medical personnel, and service standards to rival leading medical centers globally.

Adhering to these rigorous standards, Inspire IVF consistently elevates the quality of treatment and patient experience in line with international benchmarks, achieving a high success rate of 70-76% for eligible patients, in accordance with the center's medical criteria.

Ms. Kasinee Kuldiloke, Chief Executive Officer of Inspire IVF Public Company Limited ("IVF"), stated, "Infertility is increasingly recognized as a global health challenge. Data from the World Health Organization (WHO) indicates a worldwide rise in infertility, with the number of affected individuals increasing by over 20% in the past 30 years. This has led to a sustained demand for quality and accessible treatment services. However, many patients continue to face barriers such as distance, time constraints, and limited access to specialized doctors. Addressing these challenges, Inspire IVF has developed the 'Inspire IVF Telemedicine Service' to allow patients to initiate treatment planning, consult with doctors, and monitor their progress from any location worldwide."

"We believe Telemedicine transcends being merely a technological tool; it represents an evolution in patient care, making it more continuous, accessible, and aligned with the digital lifestyles of today's patients. This innovation will broaden opportunities for patients globally to access international standard treatment in Thailand. For instance, couples located in other provinces or abroad can consult with doctors, plan their treatment, review test results, and receive preliminary advice through our online system before traveling to Thailand. This approach reduces the need for multiple trips, saves time, and ensures close, continuous care from our expert medical team at every stage," Ms. Kasinee elaborated.

The Inspire IVF Telemedicine Service is designed to enhance the fertility treatment experience through several key features:

• Real-time Consultation: Online medical consultations in real-time, encompassing initial assessment, treatment planning, and ongoing treatment monitoring.
• AI Social Chatbot & 24/7 Support: An intelligent AI system providing preliminary answers, appointment reminders, and essential self-care advice during treatment, available 24 hours a day.
• Multi-language Support: Services offered in multiple languages to seamlessly cater to both Thai and international patients.
• High Security Standard: A medical data security system that adheres to international standards, safeguarding personal information and medical confidentiality.

The launch of Telemedicine IVF also signifies a crucial step in positioning Thailand as a Medical Hub for Fertility Care. By enabling patients worldwide to begin treatment planning from their home countries before traveling to Thailand, the service enhances the efficiency of the treatment process, boosts fertility tourism potential, and elevates the experience for international patients.

This investment forms part of the company's strategic growth plan under the JUMP+ project of the Stock Exchange of Thailand. This initiative aims to strengthen the competitive capabilities of listed companies through innovation, technology development, and international market expansion.

Ms. Kasinee further added, "Inspire IVF remains committed to strategic investments that build long-term competitive advantages. The company's growth strategy is founded on three key pillars: 1. International business expansion: exploring the feasibility of expanding business operations overseas. 2. Investment in high-potential businesses: evaluating investment opportunities in promising ventures within both the healthcare and non-healthcare sectors. 3. Development of medical technology and innovation: advancing new technologies such as Artificial Intelligence and Robotic Technology for future medical laboratory applications."

Under the mid-term business plan for 2026-2028, as outlined in the SET Jump+ project, the company is confident that investments in technology, enhancement of the digital patient experience, and international market expansion will be critical drivers for Inspire IVF's stable and sustainable long-term growth.

"Inspire IVF will continue to advance innovations and patient care models to make infertility treatment more accessible, convenient, and continuous, consistent with our core philosophy of 'Simplicity in Every Step'," Ms. Kasinee concluded.

Watch the Inspire IVF Telemedicine commercial: https://www.facebook.com/share/v/178nUyU3zU/

• ข่าวo:member
• ข่าวo:heal
• ข่าวo:loc
• ข่าวo:med
• ข่าวen